Baolingbao Biology Co.,Ltd.

SZSE:002286 Stock Report

Market Cap: CN¥4.0b

Baolingbao BiologyLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Sijue Dai

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentagen/a
CEO tenure4.2yrs
CEO ownershipn/a
Management average tenure7.1yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

A Look At The Intrinsic Value Of Baolingbao Biology Co.,Ltd. (SZSE:002286)

Nov 29
A Look At The Intrinsic Value Of Baolingbao Biology Co.,Ltd. (SZSE:002286)

Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues

Nov 05
Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Oct 08
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Sep 30
We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Jul 03
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Jun 07
Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

CEO

Sijue Dai (29 yo)

4.2yrs
Tenure
CN¥1,352,900
Compensation

Mr. Sijue Dai serves as a Non-Independent Director at Baolingbao Biology Co., Ltd. since March 15, 2021 and serves as its Chairman and has been its General Manager.


Leadership Team

NamePositionTenureCompensationOwnership
Sijue Dai
GM & Chairmanno dataCN¥1.35mno data
Yanjun Wang
CFO & Deputy GM7.1yrsno datano data
Xia Li
Deputy General Managerno dataCN¥514.30k0.0029%
CN¥ 116.4k
Feng Liu
Executive Deputy GM & Non-Independent Director14.3yrsCN¥812.30k0.0044%
CN¥ 174.6k
Guogang Zhang
Deputy GM & Secretary of the Board of Directors4.2yrsCN¥559.20k0.025%
CN¥ 976.6k
7.1yrs
Average Tenure
50yo
Average Age

Experienced Management: 002286's management team is seasoned and experienced (7.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sijue Dai
GM & Chairman4.2yrsCN¥1.35mno data
Feng Liu
Executive Deputy GM & Non-Independent Director14.3yrsCN¥812.30k0.0044%
CN¥ 174.6k
Huaxiao Xiao
Independent Director1.1yrsno datano data
Yongqiang Huang
Independent Director8.1yrsCN¥70.00k0.0027%
CN¥ 107.6k
Hongbo Li
Vice Chairman4.7yrsCN¥1.01m0.0039%
CN¥ 155.1k
Cuiping Qin
Non-Independent Director6.3yrsCN¥943.30k0.0039%
CN¥ 155.1k
Yurun He
Independent Director4.2yrsCN¥70.00kno data
Xin Chen
Independent Director3.7yrsCN¥70.00kno data
Bei Xu
Chairman of Board of Supervisors2.4yrsno datano data
Qiang Wang
Directorno datano data0.029%
CN¥ 1.2m
Xiaolian Zhao
Independent Directors1.1yrsno datano data
Jun Fang
Independent Directors1.1yrsno datano data
4.2yrs
Average Tenure
51.5yo
Average Age

Experienced Board: 002286's board of directors are considered experienced (4.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 10:33
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Baolingbao Biology Co.,Ltd. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
YANG QIAOChangjiang Securities Co. LTD.
Jiawei LiuDongxing Securities Company Limited